These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 14619487)

  • 1. [Effect of DC therapy combined with chemotherapy in advanced cancer cases].
    Kanazawa M; Mori Y; Yoshihara K; Iwadate M; Suzuki S; Endoh Y; Takita K; Sekikawa K; Takenoshita S; Ogata T; Ohto H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1655-60. PubMed ID: 14619487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients.
    Kanazawa M; Yoshihara K; Abe H; Iwadate M; Watanabe K; Suzuki S; Endoh Y; Takita K; Sekikawa K; Takenoshita S; Ogata T; Ohto H
    Anticancer Res; 2005; 25(1B):443-9. PubMed ID: 15816609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.
    Okuzawa M; Shinohara H; Kobayashi T; Iwamoto M; Toyoda M; Tanigawa N
    Int J Oncol; 2002 Jun; 20(6):1189-95. PubMed ID: 12011998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case report on intra-tumor injection therapy of dendritic cells in advanced gastric cancer].
    Kanazawa M; Yoshihara K; Abe H; Iwadate M; Watanabe K; Suzuki S; Endoh Y; Ohki S; Takita K; Sekikawa K; Takenoshita S; Takagi T; Irisawa A; Sato Y; Ogata T; Ohto H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1773-6. PubMed ID: 15553711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
    Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
    Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
    Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H
    Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes.
    Kanazawa M; Mori Y; Yoshihara K; Iwadate M; Suzuki S; Endoh Y; Ohki S; Takita K; Sekikawa K; Takenoshita S
    Immunol Lett; 2004 Feb; 91(2-3):229-38. PubMed ID: 15019294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
    Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
    Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines.
    Wilson CC; Olson WC; Tuting T; Rinaldo CR; Lotze MT; Storkus WJ
    J Immunol; 1999 Mar; 162(5):3070-8. PubMed ID: 10072560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic T lymphocytes having increased homing signals to cancer.
    Hong CY; Kim SY; Lee HJ; Lee SE; Lim SC; Rhee JH; Lee JJ
    J Immunother; 2014 Jan; 37(1):16-25. PubMed ID: 24316552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.